MC

471.05

-0.04%↓

SANES

7.059

+0.26%↑

BNP

78.09

+1.13%↑

ALV

354.5

+0.25%↑

MUV2

575.8

+0.07%↑

MC

471.05

-0.04%↓

SANES

7.059

+0.26%↑

BNP

78.09

+1.13%↑

ALV

354.5

+0.25%↑

MUV2

575.8

+0.07%↑

MC

471.05

-0.04%↓

SANES

7.059

+0.26%↑

BNP

78.09

+1.13%↑

ALV

354.5

+0.25%↑

MUV2

575.8

+0.07%↑

MC

471.05

-0.04%↓

SANES

7.059

+0.26%↑

BNP

78.09

+1.13%↑

ALV

354.5

+0.25%↑

MUV2

575.8

+0.07%↑

MC

471.05

-0.04%↓

SANES

7.059

+0.26%↑

BNP

78.09

+1.13%↑

ALV

354.5

+0.25%↑

MUV2

575.8

+0.07%↑

Search

Sartorius Stedim Biotech.

Suletud

SektorRahandus

193.3 -0.1

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

188.55

Max

195.2

Põhinäitajad

By Trading Economics

Sissetulek

75M

115M

Müük

-6.7M

745M

P/E

Sektori keskmine

89.81

24.968

Aktsiakasum

1.16

Dividenditootlus

0.36

Kasumimarginaal

15.498

Töötajad

9,961

EBITDA

124M

256M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+21.06% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.36%

4.18%

Järgmine tulemuste avaldamine

22. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

2.3B

19B

Eelmine avamishind

193.4

Eelmine sulgemishind

193.3

Uudiste sentiment

By Acuity

13%

87%

14 / 538 Pingereas Finance

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Sartorius Stedim Biotech. Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. juuni 2025, 20:45 UTC

Tulu

Broadcom 2Q Sales Climb on Booming AI Demand

5. juuni 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5. juuni 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5. juuni 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5. juuni 2025, 21:32 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. juuni 2025, 20:45 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:24 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Rev $15B >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Net $4.97B >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Adj EPS $1.58 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q EPS $1.03 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom Sees 3Q Rev $15.8B >AVGO

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5. juuni 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5. juuni 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5. juuni 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5. juuni 2025, 18:26 UTC

Tulu

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5. juuni 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5. juuni 2025, 16:30 UTC

Omandamised, ülevõtmised, äriostud

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5. juuni 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. juuni 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5. juuni 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5. juuni 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5. juuni 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5. juuni 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5. juuni 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Sartorius Stedim Biotech. Prognoos

Hinnasiht

By TipRanks

21.06% tõus

12 kuu keskmine prognoos

Keskmine 234.67 EUR  21.06%

Kõrge 250 EUR

Madal 210 EUR

Põhineb 9 Wall Streeti analüütiku instrumendi Sartorius Stedim Biotech. 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

9 ratings

5

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

202.7 / 211.7Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

14 / 538 Pingereas Rahandus

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.